May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Detection and Quantitation of mRNA of Matrix Metalloproteinase Enzymes in Cultured Human Trabecular Meshwork and Ciliary Body Treated with Latanoprost.
Author Affiliations & Notes
  • D.–J. Oh
    Lab. for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • J.L. Martin
    Lab. for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • A.J. Williams
    Lab. for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • C. Pokorny
    Lab. for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • P. Russell
    Lab. of Mechanisms of Ocular Diseases, NEI, Bethesda, MD
  • D.E. Birk
    Dept. of Anatomy, Patholgy and Cell Biology, Thomas Jefferson University, Philadelphia, PA
  • D.J. Rhee
    Lab. for Molecular Ophthalmology, Wills Eye Hospital, Philadelphia, PA
  • Footnotes
    Commercial Relationships  D. Oh, None; J.L. Martin, None; A.J. Williams, None; C. Pokorny, None; P. Russell, None; D.E. Birk, None; D.J. Rhee, Pfizer C, R; Allegan C, R.
  • Footnotes
    Support  EY13997–01(DJR), Pfizer, Allegan
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4374. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.–J. Oh, J.L. Martin, A.J. Williams, C. Pokorny, P. Russell, D.E. Birk, D.J. Rhee; Detection and Quantitation of mRNA of Matrix Metalloproteinase Enzymes in Cultured Human Trabecular Meshwork and Ciliary Body Treated with Latanoprost. . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4374.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: We set out to determine the expression pattern of all the known matrix metalloproteinases (MMPs) in human trabecular meshwork (TM) as well as ciliary body (CB) and to examine their transcriptional response to incubation with latanoprost. Methods: The presence of MMPs was examined, using RT–PCR, in human TM and CB tissues as well as cultures of TM endothelial and CB smooth muscle (CBSM) cells. The PCR products were sequenced and compared against the Genbank database. The transcriptional response to latanoprost was assessed using quantitative RT–PCR in control and latanoprost–treated cultures of TM endothelial and CBSM cells. The cultures were incubated with 30 ng/µl, 300 ng/µl, and 3 µg/µl of latanoprost for 24 hours. The comparative CT method was used to quantify target genes relative to GAPDH as a reference. Results: There was no difference in the mRNA expression pattern of MMPs between TM and CB. MMP–11, –12, –14, –15, –16, –17, –19, –24 as well as MMP–1, –2 , –3 were transcribed in both tissues and cultures of TM and CBSM cells. MMP–25 was transcribed in both TM and CB tissues, but not in cultures of TM and CBSM. In response to latanoprost incubation at therapeutic level (30 ng/µl), cultures of TM showed that MMP–11 and –12 were up–regulated, while MMP–16, –17 and –19 were down–regulated, and MMP–14 and –15 were not changed. In CBSM cultures, MMP–3, –11, –15 and –17 were up–regulated, while MMP–14 and –19 were down–regulated. MMP–16 is unchanged. Variability among three individuals was noted. Conclusions: The results showed that MMP–1, –2, –3, –11, –12, –19 and all membrane–type MMPs (MT–MMPs) except MMP–25 (MT6–MMP) are transcribed with no difference in the pattern of expression between TM and CB, and also that incubation with latanoprost may induce transcriptional changes of MMPs in both of tissues. These results suggest that MMPs –15 and –17 may play a role in latanoprost–mediated increased uveoscleral outflow.

Keywords: outflow: trabecular meshwork • outflow: ciliary muscle • gene/expression 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×